Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseAdam C. Naj, Charles DeCarli, Gyungah Jun et al.|Nature Genetics|2011Cited by 2k
Neuroimaging standards for research into small vessel disease—advances since 2013Marco Duering, Hugh S. Markus, Rosalind Brown et al.|The Lancet Neurology|2023Cited by 962
Genomewide Association Studies of StrokeM. Arfan Ikram, Philip A. Wolf, Sudha Seshadri et al.|New England Journal of Medicine|2009Cited by 463
Predicting Alzheimer’s disease progression using multi-modal deep learning approachGaram Lee, Prashanthi Vemuri, Kwangsik Nho et al.|Scientific Reports|2019Cited by 401
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's diseaseClifford R. Jack, Norman L. Foster, Frederik Barkhof et al.|Alzheimer s & Dementia|2011Cited by 220